Profile

panCELLa has created platforms  that allow for the development of safe, universal, “off-the-shelf” cell lines. Our mandate is to accelerate cell-based therapies to a broad range of diseases by providing safe therapeutic cell products.  We license cell lines incorporated with our FailSafeTM and induced Allogeneic Cell Tolerance (iACT Stealth CellsTM) in addition to developing our own MSC- and NK-based therapeutic products.

panCELLa Logo

Website

pancella.com

Contact


Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

34 in total